文献速递心律失常冠心病

左心耳封堵与口服抗凝:并非免费午餐

Left Atrial Appendage Occlusion vs Oral Anticoagulation—No Free Lunch
RSS 订阅 · JAMA Cardiology · 2026-10-01

本文为JAMA Cardiology评论,围绕房颤患者左心耳封堵(LAAO)与口服抗凝(OAC)的选择展开。文章指出OAC虽有效但依从性受出血、不良反应和费用影响,LAAO理论上可减少栓塞与出血,但存在操作并发症、封堵不完全、器械相关血栓及术后抗栓需求。2023年ACC/AHA/ACCP/HRS指南将LAAO列为高出血风险房颤患者基于偏好的OAC替代选择(2b类)。

要点

  • 非风湿性房颤约90%的栓塞性卒中源于左心耳血栓。
  • LAAO存在操作并发症、封堵不完全、器械相关血栓及术后抗栓需求。
  • 2023年指南将LAAO列为高出血风险患者OAC替代选择(2b类)。

核心结论

  • LAAO并非无代价的OAC替代方案,需权衡操作风险、器械相关血栓及术后抗栓需求。

研究设计与样本

  • 本文为JAMA Cardiology评论,引用经食管超声和尸检数据及2023年ACC/AHA/ACCP/HRS指南。

主要发现

  • 经食管超声和尸检数据提示非风湿性房颤患者约90%的栓塞性卒中由左心耳血栓引起。
  • OAC虽高效降低卒中风险,但出血风险、瘀斑等不良反应及费用影响依从性。
  • LAAO风险包括操作并发症、封堵不完全、器械相关血栓及术后需抗栓治疗。

关键数值与推荐

  • 2023年ACC/AHA/ACCP/HRS指南:对高 major 出血风险的房颤患者,基于患者偏好,经皮LAAO可作为OAC的合理替代(2b类)。

临床怎么用

  • 对高出血风险且偏好非OAC方案的房颤患者,可个体化讨论LAAO,但需告知操作风险及术后抗栓需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF) is a leading cause of ischemic stroke. Moreover, strokes due to AF are more likely to have larger infarct volume, more frequent hemorrhagic transformation, and more severe disability and mortality. Oral anticoagulation (OAC) is recommended in individuals with AF who are at increased risk for stroke. Although OAC is highly effective at reducing the risk of stroke, adherence to OAC is challenging due to the risk of bleeding, adverse effects like bruising, and financial cost. Transesophageal echocardiography and autopsy data suggest that approximately 90% of embolic strokes in individuals with nonrheumatic AF are due to thrombi that originate in the left atrial appendage. Thus, in theory, percutaneous left atrial appendage occlusion (LAAO) should reduce the risk of ischemic stroke and reduce the risk of bleeding if patients can discontinue OAC. Yet as with any procedure, LAAO has risks, including procedural complications, incomplete seal, device-related thrombus, and a need for postprocedural antithrombotic therapy. The 2023 American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Clinical Pharmacy (ACCP)/Heart Rhythm Society (HRS) guidelines state that percutaneous LAAO may be a reasonable alternative to OAC based on patient preference in those with AF who have a high risk of major bleeding (class 2b).

来源:JAMA Cardiology,查看原文。版权归原作者所有。

引用

  1. JAMA Cardiology:Left Atrial Appendage Occlusion vs Oral Anticoagulation—No Free Lunch

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。